Clinical implications of cancer stem cell biology in hepatocellular carcinoma

Seminars in Oncology

Volumn 39, Issue 4, 2012, Pages 461-472

  Ji, Junfang ^a   Wang, Xin Wei ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD24 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL HOMING; CELL PROLIFERATION; CELL RENEWAL; CONFERENCE PAPER; CYTOLOGY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; SURVIVAL RATE; SURVIVAL TIME;

ANTIGENS, CD; ANTIGENS, CD24; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; DRUG RESISTANCE, NEOPLASM; GLYCOPROTEINS; HUMANS; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS;

EID: 84864465226     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.05.011     Document Type: Conference Paper

References (89)

1. M.F. Clarke Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 2006 9339 9344
2. P.B. Gupta, C.L. Chaffer, R.A. Weinberg Cancer stem cells: mirage or reality? Nat Med 15 2009 1010 1012
3. T. Lapidot A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648
4. M. Al-Hajj, M.S. Wicha, A. ito-Hernandez, S.J. Morrison, M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
5. M. Al Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
6. S.K. Singh Identification of human brain tumour initiating cells Nature 432 2004 396 401
7. D. Bonnet, J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 1997 730 737
8. L. Ricci-Vitiani Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
9. C.A. O'Brien, A. Pollett, S. Gallinger, J.E. Dick A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
10. T. Yamashita EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 2009 1012 1024
11. M. Dean, T. Fojo, S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284
12. J.N. Rich Cancer stem cells in radiation resistance Cancer Res 67 2007 8980 8984
13. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
14. F.X. Bosch, J. Ribes, M. Diaz, R. Cleries Primary liver cancer: worldwide incidence and trends Gastroenterology 127 2004 S5 S16
15. H.B. El-Serag, A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
16. X.W. Wang Molecular pathogenesis of human hepatocellular carcinoma Toxicology 181-182 2002 43 47
17. H.B. El Serag, K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
18. S.S. Thorgeirsson, J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 2002 339 346
19. B. Vogelstein, K.W. Kinzler Cancer genes and the pathways they control Nat Med 10 2004 789 799
20. D. Hanahan, R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
21. J. Ji MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
22. J. Ji, X.W. Wang New kids on the block: Diagnostic and prognostic microRNAs in hepatocellular carcinoma Cancer Biol Ther 8 2009 1686 1693
23. Q.H. Ye Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 2003 416 423
24. N. Iizuka Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 2003 923 929
25. J.S. Lee Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
26. A. Budhu Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907
27. J. Zucman-Rossi Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Hepatology 43 2006 515 524
28. T. Yamashita EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461
29. E. Schmelzer, L.M. Reid EpCAM expression in normal, non-pathological tissues Front Biosci 13 2008 3096 3100
30. E. Schmelzer Human hepatic stem cells from fetal and postnatal donors J Exp Med 204 2007 1973 1987
31. J.W. Kim Cancer-associated molecular signature in the tissue samples of patients with cirrhosis Hepatology 39 2004 518 527
32. T. Yamashita, A. Budhu, M. Forgues, X.W. Wang Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling in hepatocellular carcinoma Cancer Res 67 2007 10831 10839
33. A. Suetsugu, M. Nagaki, H. Aoki, T. Motohashi, T. Kunisada, H. Moriwaki Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells Biochem Biophys Res Commun 351 2006 820 824
34. S. Yin CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity Int. J. Cancer 120 2007 1444 1450
35. S. Ma Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 132 2007 2542 2556
36. A. Tsuchiya Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas Hepatol Res 39 2009 1080 1090
37. S. Yoshikawa Characterization of CD133+ parenchymal cells in the liver: histology and culture World J. Gastroenterol 15 2009 4896 4906
38. K. Kemper The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation Cancer Res 70 2010 719 729
39. T.A. Rege, J.S. Hagood Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis FASEB J 20 2006 1045 1054
40. R.W. Cho Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors Stem Cells 2007
41. G. Liu Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Mol Cancer 5 2006 67
42. Y.Y. Dan Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages Proc Natl Acad Sci U S A 103 2006 9912 9917
43. Z.F. Yang Significance of CD90(+) Cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
44. Z.F. Yang Identification of local and circulating cancer stem cells in human liver cancer Hepatology 47 2008 919 928
45. N.M. Masson, I.S. Currie, J.D. Terrace, O.J. Garden, R.W. Parks, J.A. Ross Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1 Am J Physiol Gastrointest Liver Physiol 291 2006 G45 G54
46. Z. Zhu Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma Int. J Cancer 126 2010 2067 2078
47. T.K. Lee, A. Castilho, V.C. Cheung, K.H. Tang, S. Ma, I.O. Ng CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation Cell Stem Cell 9 2011 50 63
48. H. Hashida Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer Gastroenterology 122 2002 376 386
49. N. Petrovic CD13/APN regulates endothelial invasion and filopodia formation Blood 110 2007 142 150
50. N. Haraguchi CD13 is a therapeutic target in human liver cancer stem cells J Clin Invest 120 2010 3326 3339
51. C.C. Hsia, R.P. Evarts, H. Nakatsukasa, E.R. Marsden, S.S. Thorgeirsson Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis Hepatology 16 1992 1327 1333
52. P. Ruck, J.C. Xiao, T. Pietsch, S.D. Von, E. Kaiserling Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6 Histopathology 31 1997 324 329
53. W. Yang Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells Cancer Res 68 2008 4287 4295
54. T. Chiba Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties Hepatology 44 2006 240 251
55. N. Haraguchi Characterization of a side population of cancer cells from human gastrointestinal system Stem Cells 24 2006 506 513
56. G.M. Shi Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials J Cancer Res Clin Oncol 134 2008 1155 1163
57. C. Hu Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling Carcinogenesis 29 2008 2289 2297
58. Y. Zen Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma Am J Pathol 170 2007 1750 1762
59. D.J. Pearce Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples Stem Cells 23 2005 752 760
60. C. Ginestier ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
61. S. Ma Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations Mol. Cancer Res. 6 2008 1146 1153
62. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
63. C. Cavard Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology Future. Oncol. 4 2008 647 660
64. J. Ji Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells Hepatology 50 2009 472 480
65. J. Ji, T. Yamashita, X.W. Wang Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma Cell Biosci 1 2011 4
66. X.R. Yang CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clin Cancer Res 15 2009 5518 5527
67. C.K. Lau An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells Clin Cancer Res 15 2009 3462 3471
68. T.K. Lee, A. Castilho, V.C. Cheung, K.H. Tang, S. Ma, I.O. Ng Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation Hepatology 53 2011 160 170
69. S. Ma, T.K. Lee, B.J. Zheng, K.W. Chan, X.Y. Guan CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway Oncogene 27 2008 1749 1758
70. Y. Tang Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling Proc Natl Acad Sci U S A 105 2008 2445 2450
71. H. You, W. Ding, C.B. Rountree Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta Hepatology 51 2010 1635 1644
72. T. Yamashita Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation Cancer Res 70 2010 4687 4697
73. N. Fausto Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells Hepatology 39 2004 1477 1487
74. Johnson PJ The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma Clin Liver Dis 5 2001 145 159
75. S. Maheswaran Detection of mutations in EGFR in circulating lung-cancer cells N Engl J Med 359 2008 366 377
76. W. Song Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma Int J Clin Pract 62 2008 1212 1218
77. C.T. Yeh CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection BMC. Cancer 9 2009 324
78. A. Sasaki Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma Oncol Rep 24 2010 537 546
79. J.W. Lu, J.G. Chang, K.T. Yeh, R.M. Chen, J.J. Tsai, R.M. Hu Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis Acta Histochem 113 2011 833 838
80. K. Hirohashi CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma Hepatogastroenterology 51 2004 1121 1123
81. K. Endo, T. Terada Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival J Hepatol 32 2000 78 84
82. X.R. Yang High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma Gut. 59 2010 953 962
83. O. Rosmorduc, C. Housset Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease Semin. Liver Dis. 30 2010 258 270
84. T. Chiba The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma Cancer Res 68 2008 7742 7749
85. S. Ma miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1 Cell Stem Cell 7 2010 694 707
86. J. Zhang, N. Luo, Y. Luo, Z. Peng, T. Zhang, S. Li microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb Int J Oncol 40 2012 747 756
87. C. Yin Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene Hepatology 48 2008 1528 1539
88. C. Tomuleasa Arsenic trioxide plus cisplatin/interferon alpha-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma Hematol Oncol Stem Cell Ther 4 2011 60 66
89. S.T. Cheung, P.F. Cheung, C.K. Cheng, N.C. Wong, S.T. Fan Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance Gastroenterology 140 2011 344 355